Matching slides 60,568
Current window 38,371-38,400
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all

Component

38,371-38,400 of 60,568

filter-aware
22
This is a standard financial disclosure table showing historical adjustments to GAAP net income.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
24
This is a standard financial disclosure slide for non-GAAP metrics.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
06
Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Agitation1 hit
07
The slide uses a hierarchical testing procedure for statistical significance.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Solution1 hit
09
The slide uses a stacked bar chart to visualize the response rates and a table to detail specific IWG criteria outcomes.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Comparative Analysis1 hit
13
The table compares adverse events (TEAEs) and specific common events between treatment and placebo groups.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
16
Includes a forest plot for subgroup analysis and a summary table for prior treatments.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
17
The slide uses a mirrored bar chart to compare adverse event frequencies by grade, alongside a summary table of clinical safety outcomes.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
21
The slide presents clinical trial baseline data, likely for a breast cancer study given the markers (ER+, PgR+, ESR1m, CDK4/6i).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
22
The slide uses a standard Kaplan-Meier survival analysis framework common in oncology clinical trials.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
24
Clinical trial data visualization showing progression-free survival (PFS) curves with associated hazard ratios and event counts.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
27
The table compares adverse event (AE) frequencies, treatment-related AEs (TRAEs), and dose modifications.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
28
The table lists 15 specific adverse events plus 'Any AE' across 4 cohorts, with two columns per cohort (All grades, Grade >=3).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
41
Clinical trial baseline characteristics table.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
25
Uses a Good-Better-Best-Premium framework to organize product offerings.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Product1 hit
27
The slide uses a split-screen layout to compare two distinct business units under the AZEK Company umbrella.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Product1 hit
30
Includes a waterfall-style diagram for the Sales Growth Equation.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Financials1 hit
32
Azek | Investor Presentation Deck | 37 slidesAzek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Financials1 hit
33
Includes revenue, EBITDA, net income, EPS, cash flow, capex, leverage, and RONTA.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · Financials1 hit
12
The slide uses a split-screen layout: historical performance on the left, strategic growth levers on the right.Azerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations Beat · Business Model1 hit
35
The slide uses a table to compare strategic rationale across three distinct M&A deals.Azerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations 1 hit
38
Includes a disclaimer about accounting standards (Dutch GAAP vs IFRS).Azerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations Beat · Financials1 hit
39
Azerion | Investor Day Presentation Deck | 48 slidesAzerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations Beat · Financials1 hit
44
The slide uses a combination of bar charts for financial figures and a table row for gross profit margin percentages.Azerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations Beat · Financials1 hit
45
Includes revenue, adjusted EBITDA, gross profit margin, and user engagement metrics.Azerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations 1 hit
48
Azerion | Investor Day Presentation Deck | 48 slidesAzerion | Investor Day Presentation Deck | 48 slides · Azerion
Conference presentation Investor relations 1 hit
12
The slide uses a timeline-to-table hybrid structure to show product evolution and market positioning.Berkeley Lights | Mergers and Acquisitions Presentation Deck | 17 slides · Berkeley Lights
Conference presentation Investment bank 1 hit
05
Includes confidential treatment redactions and market data note.Goldman Sachs | Investment Banking Pitch Book | 52 slides · Goldman Sachs
Consulting deck Investment bank Beat · Problem & Complication1 hit
06
Includes specific transaction details like price per share, premium percentage, and advisor names.Goldman Sachs | Investment Banking Pitch Book | 52 slides · Goldman Sachs
Consulting deck Investment bank Beat · Problem & Complication1 hit
10
The slide includes a data table summarizing performance metrics (YTD, 1Y, 3Y, Since Last Follow-On, Since IPO) for each category.Goldman Sachs | Investment Banking Pitch Book | 52 slides · Goldman Sachs
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit